When it comes to maintaining compliance with international ISO standards, resting on your laurels is not an option. For modern businesses, continuous regulatory monitoring is no longer just a best practice; it is an absolute necessity. Organizations must stay ahead of shifting guidelines, localized laws, and global standards to keep their certifications intact and their operations running smoothly.
Nowhere is this need more stringent, and the stakes higher, than in the Biotech and Medtech sectors.
At Ditto, we have watched our partners in the life sciences industry face an increasingly complex web of global regulations. Missing a single regulatory update can mean delayed product launches, costly compliance gaps, and risks to patient safety. Recognizing this massive industry hurdle, we decided it was time to build a specialized solution.
From Stealth to Public: The Launch of Qalico
Six months ago, we set out to solve the regulatory monitoring headache for our clients. We launched a dedicated, highly specialized team tasked with one mission: to build the ultimate compliance monitoring engine for the life sciences sector.
After half a year of refining our processes and building our database, we are officially taking this initiative public.
Today, we are thrilled to formally introduce Qalico, an independent team working within the broader Ditto ecosystem.
Through Qalico, we are now proud to offer the most comprehensive regulatory intelligence monitoring on the market. Our platform is designed to cut through the noise, actively tracking regulations, changing guidelines, and critical industry news across 100+ countries.
By leveraging Qalico's dedicated expertise, QA and RA (Quality and Regulatory Affairs) teams in biotech and medtech can finally transition from reactive scrambling to proactive compliance.
Why Medtech and Biotech Need Specialized Monitoring
The regulatory landscape for medical devices and biotechnology is notoriously fragmented. A guideline update from the FDA in the United States, a new MDR provision in Europe, or shifting clinical trial requirements in the Asia-Pacific region can all happen simultaneously.
To maintain essential certifications like ISO 13485 (Quality Management for Medical Devices), companies must prove they have robust processes in place to monitor and adapt to these regulatory changes. Qalico provides the exact framework needed to meet these rigorous auditor expectations, ensuring that no geographic or regulatory update slips through the cracks.
Looking Ahead: Expanding to ESG, ISO 9001, and ISO 14001
While our current laser focus is on the highly regulated medtech and biotech verticals, our vision for the coming months is much broader.
Regulatory monitoring is just as critical for broader quality and sustainability goals. We are actively developing intelligence streams to serve our customers' needs across:
- ISO 9001 — The global standard for Quality Management Systems (QMS)
- ISO 14001 — The global standard for Environmental Management Systems (EMS)
- ESG (Environmental, Social, and Governance) — Tracking the rapidly evolving corporate sustainability reporting directives and global ESG mandates
As the regulatory landscape expands, so will we.
Built by Ditto, Powered by Qalico
We understand that deep, vertical-specific challenges require dedicated focus. By operating as an independent team inside the broader Ditto family, Qalico maintains the agility of a specialized startup while benefiting from the robust infrastructure and reliability that Ditto customers already trust.
If your organization is struggling to keep pace with global medical device and biotechnology regulations, it is time to upgrade your regulatory intelligence.
Discover how our dedicated team can streamline your ISO compliance today by visiting Qalico.com
Bon à savoir : Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
